Cervical Cancer Vaccine Gets Lukewarm Reception Despite MN Approval
A University of Minnesota survey shows less than half (48 percent) of parents who share this view support the use of the vaccine. Overall, however, 87 percent of Minnesotans surveyed support the vaccine use. The survey findings were published in the Journal of Adolescent Health. The vaccine to immunize young women against the human papillomavirus, a sexually-transmitted virus that causes cervical cancer, has not received the warm welcome public health advocates had hoped for.
- New vaccine for Breast cancer effective in lab
- ImmunoCellular’s Cancer Vaccine Demonstrates Immune Response Against Brain Cancer
- Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease
- Kansas cancer screening program runs out of funds
